Answers are grounded in this paper and cite their sources.
Demonstrates the anti-angiogenic effects of fucoidan/bis-MPA dendrimer nanoparticles in oncology, suggesting novel therapeutic applications.
Nanoparticles with intrinsic anti-angiogenic activity hold strong promise in cancer nanomedicine, as they can both help suppress metastasis and deliver therapeutics, offering a dual strategy for addressing the disease.
No takes yet. Share an insight, caveat, or question.
Olim et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: